Global Antibiotics Market Analysis Report 2021-2028: Key Players Focus on Research and Innovation to Stay Competitive and Develop New Antimicrobial Therapies


DUBLIN, March 08, 2022–(BUSINESS WIRE)–The Report “Antibiotics Market Share, Size, Trends, Industry Analysis Report, By Product; By Application: By End Use; By Region; Segment Forecast, 2021-2028 ” has been added to from offer.

Global antibiotics market size expected to reach USD 51.5 billion by 2028

Collaboration between pharmaceutical companies is driving the growth of the industry. Pharmaceutical companies around the world are stepping up their research efforts to develop new therapies and reduce the costly burden of drug discovery. In this sense, in July 2019, Nosopharm partnered with Evotec to develop NOSO-502, a new antibiotic to treat Enterobacteriaceae infections. Similarly, in April 2019, Forge Therapeutics and Basilea Pharma announced a research and licensing agreement to develop new antibiotics.

Moreover, the increase in public-private collaborations to finance projects related to this industry is also expected to boost the market growth. For example, in March 2019, the Global Antibiotic Research and Development Partnership (GARDP) announced a collaboration with Evotec to develop first-in-class antibiotics for the treatment of drug-resistant bacteria.

Market players such as Abbott Laboratories, Allergan, Bayer AG, Cumberland Pharmaceuticals, Inc., Danaher, GlaxoSmithKline plc, Melinta Therapeutics, Merck & Co. Inc., Mylan, Nabriva Therapeutics plc, Novartis, Pfizer Inc., Roche, Sanofi, Teva Pharmaceutical Industries Ltd. Pharmaceutical companies around the world are focusing on research and innovation to stay competitive and develop new antimicrobial therapies.

With this in mind, in July 2020, more than dozens of pharmaceutical companies launched the AMR Action Fund, a collaborative effort to develop three to four new antibiotics by the end of the decade. The group has already raised more than $1 billion to support clinical research into new antibiotics to fight life-threatening infections.

The fund would provide potential antibiotic candidates for the most challenging stages of drug development and enable individual governments to make favorable reforms to potential product pipelines.

Main topics covered:

1. Introduction

1.1. Description of the report

1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research methodology

3.1. Overview

3.1.1. Data mining

3.2. Data sources

3.2.1. Primary sources

3.2.2. Secondary sources

4. Antibiotics Market Overview

4.1. Antibiotics Market – Industry Overview

4.2. Antibiotics Market Dynamics

4.2.1. Drivers and opportunities

4.2.2. Constraints and challenges

4.3. Porter’s Five Forces Analysis

4.4. PESTLE analysis

4.5. Antibiotics Market Industry Trends

4.6. COVID-19 Impact Analysis

5. Global Antibiotics Market, By Product

5.1. Main conclusions

5.2. introduction

5.2.1. Global Antibiotics Market, by Product, 2016-2028 (USD Billion)

5.3. Software

5.4. Device

5.5. storage system

6. Global Antibiotics Market, By Application

6.1. Main conclusions

6.2. introduction

6.2.1. Global Antibiotics Market, by Application, 2016-2028 (USD Billion)

6.3. Drug discovery and development

6.4. Academic research

6.5. Diagnosis of the disease

7. Global Antibiotics Market, By End Use

7.1. Main conclusions

7.2. introduction

7.2.1. Global Antibiotics Market, By End Use, 2016-2028 (USD Billion)

7.3. Hospitals

7.4. Biotechnology and pharmaceutical companies

7.5. Diagnostic laboratories

7.6. Academic and research institutes

8. Global Antibiotics Market, By Geography

8.1. Main conclusions

8.2. introduction

8.2.1. Antibiotics market valuation, by geography, 2016-2028 (USD billion)

9. Competitive landscape

9.1. Expansion and acquisition analysis

9.1.1. Expansion

9.1.2. Acquisitions

9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Company presentation

10.2. Financial performance

10.3. Product Benchmarking


For more information about this report visit

See the source version on

Laura Wood, Senior Press Officer

For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900


Comments are closed.